Tardive Dyskinesia Video Perspectives

Andres Deik, MD

Deik reports receiving funding for clinical trials from Teva Pharmaceuticals.
April 18, 2023
2 min watch
Save

VIDEO: How pharmacologic treatments reduce symptoms of TD

Transcript

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify iwaters@healio.com if there are concerns regarding accuracy of the transcription.

Yes, so pharmacological treatments definitely can reduce symptoms of TD. As I was mentioning before, the new agents that are added are very like symptomatic therapies for TD, which can reduce the severity of the movements, particularly when the movements are more chorea form in nature. Botulinum toxin injections have been approved for the treatment of dystonia for many years now. And that includes tardive dystonia patients, certainly in my practice, who I see who come in with very fixed dystonias that are presumably caused by exposure to neuroleptics or prokinetic agents respond very nicely to these injections. So these treatments can definitely be very, very helpful. There's also oral medications that we would use to treat mixed movement disorders, agents like clonazepam, for example, which we used in the movement disorder field to treat all kinds of different movement disorders: tremor, dystonia, chorea certainly also help for the treatment of tardive. And then as I was mentioning before, there are these other agents that are more experimental and have less of evidence behind them but can also be employed. So there is a number of different strategies to try to mitigate the severity of these symptoms. And I think the importance is recognition of the symptoms and early referral if possible to a limited or a specialist who can offer these treatments to the patients.